Gilead Sciences, Inc. (GILD)
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
Recs
valustion too high but if stock dipps below 40 a must own.
Recs
Recs
r&d is too costly to gild and is beginning to fell the economic pressures just like the rest of us.
you will see the normal run up before its scheduled 2:1 stock split next month,
BUT i would sell just before
that happens and look up those gains NOW and wait until gild has something else in its stale and unyielding pipeline!!!
Recs
It's been up on rumors. It's due for a fall.
Recs
overextended.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 5 of 5